# COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)

> **NCT05055466** · — · COMPLETED · sponsor: **St. Anna Kinderkrebsforschung** · enrollment: 283 (actual)

## Conditions studied

- SARS-CoV-2 Infection
- Covid19
- Intestinal Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05055466
- **Lead sponsor:** St. Anna Kinderkrebsforschung
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-06
- **Primary completion:** 2022-03-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05055466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05055466, "COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05055466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*